Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Safety Could Differentiate Nkarta’s CAR-NK Cell Therapy
Allogeneic Therapy Can Be Re-Dosed
Dec 07 2022
•
By
Andrew McConaghie
Harnessing the power of natural killer cells could prove to be superior to CAR-Ts, especially on safety. • Source: Shutterstock
More from Business
More from Scrip